Literature DB >> 35258488

Stapled Full-Thickness Diaphragm Resection: A Novel Approach to Diaphragmatic Resection in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.

David N Hanna1, Cameron Schlegel2, Muhammad O Ghani1, Andrew Hermina3, Alexander S Mina4, Katlyn McKay4, Christina E Bailey1, Deepa Magge1, Kamran Idrees1.   

Abstract

Full-thickness diaphragm resection (FT-DR) during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is sometimes required to achieve a complete cytoreduction. It is conventionally performed with electrocautery with primary repair or mesh repair. FT-DR using a linear cutting stapler is a novel technique that avoids entry to the chest cavity and minimizes the use of electrocautery on the diaphragm. We performed an institutional retrospective review of a prospectively maintained database of 145 patients who underwent CRS-HIPEC between 2013 and 2019. Patients were divided into the Conventional or Stapled group based on the FT-DR approach indicated in the operative report. Of the 145 patients who underwent CRS-HIPEC, 27 underwent FT-DR, with 63% (n = 17) in the Stapled group. There were no significant demographic or oncologic differences between the 2 groups. Patients in the Stapled group underwent tube thoracostomy (13.3% vs 60%; p = 0.008), were diagnosed with pneumonia (12% vs 50%; p = 0.04), required reintubation (6% vs 40%; p = 0.03), and required mechanical ventilation more than 48 hours (6% vs 50%; p = 0.02) less frequently than the Conventional group. There was no difference in pleural recurrence between the 2 groups (Conventional 20% vs Stapled 12%, p = 0.56). Stapled full-thickness diaphragm resection is a novel approach to achieving a complete cytoreduction that excludes the pleural cavity, minimizes diaphragm manipulation, and is associated with improved postoperative pulmonary outcomes in patients undergoing CRS-HIPEC.
Copyright © 2022 by the American College of Surgeons. Published by Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35258488      PMCID: PMC9203920          DOI: 10.1097/XCS.0000000000000152

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.532


  17 in total

1.  Pleuropulmonary Recurrence Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Appendiceal Pseudomyxoma Peritonei.

Authors:  Joal D Beane; Gregory C Wilson; Jeffrey M Sutton; Yongli Shuai; Lekshmi Ramalingam; Heather L Jones; James F Pingpank; Matthew P Holtzman; Amer J Zureikat; Steven A Ahrendt; Herbert J Zeh; David L Bartlett; Haroon A Choudry
Journal:  Ann Surg Oncol       Date:  2019-01-08       Impact factor: 5.344

2.  Long term survival and perioperative propensity score matched outcomes of diaphragmatic resections compared to stripping in cytoreductive surgery + intra-peritoneal chemotherapy.

Authors:  Bhavneet Singh; Gurkirat Singh; Nayef Alzahrani; David L Morris
Journal:  Am J Surg       Date:  2019-06-23       Impact factor: 2.565

Review 3.  Peritoneal carcinomatosis: cytoreductive surgery and HIPEC--overview and basics.

Authors:  Björn L D M Brücher; Pompiliu Piso; Vic Verwaal; Jesus Esquivel; Marcello Derraco; Yutaka Yonemura; Santiago Gonzalez-Moreno; Jörg Pelz; Alfred Königsrainer; Michael Ströhlein; Edward A Levine; David Morris; David Bartlett; Olivier Glehen; Alfredo Garofalo; Aviram Nissan
Journal:  Cancer Invest       Date:  2012-03       Impact factor: 2.176

4.  Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Terence C Chua; Brendan J Moran; Paul H Sugarbaker; Edward A Levine; Olivier Glehen; François N Gilly; Dario Baratti; Marcello Deraco; Dominique Elias; Armando Sardi; Winston Liauw; Tristan D Yan; Pedro Barrios; Alberto Gómez Portilla; Ignace H J T de Hingh; Wim P Ceelen; Joerg O Pelz; Pompiliu Piso; Santiago González-Moreno; Kurt Van Der Speeten; David L Morris
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

5.  Full-thickness diaphragmatic resection for stage IV ovarian carcinoma using the EndoGIA stapling device followed by diaphragmatic reconstruction using a Gore-tex graft: a case report and review of the literature.

Authors:  Margrit M Juretzka; Faith R Horton; Nadeem R Abu-Rustum; Yukio Sonoda; William R Jarnagin; Raja M Flores; Richard Barakat; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2005-10-14       Impact factor: 5.482

6.  Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis.

Authors:  Perry Shen; Edward A Levine; Jason Hall; Doug Case; Greg Russell; Ronald Fleming; Richard McQuellon; Kim R Geisinger; Brian W Loggie
Journal:  Arch Surg       Date:  2003-01

Review 7.  Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and future.

Authors:  Ahmed Dehal; J Joshua Smith; Garrett M Nash
Journal:  J Gastrointest Oncol       Date:  2016-02

8.  Intrathoracic Chemoperfusion Decreases Recurrences in Patients with Full-Thickness Diaphragm Involvement with Mucinous Appendiceal Adenocarcinoma.

Authors:  Travis E Grotz; Paul F Mansfield; Richard E Royal; Gary N Mann; Safia Rafeeq; Karen A Beaty; Michael J Overman; Keith F Fournier
Journal:  Ann Surg Oncol       Date:  2016-03-30       Impact factor: 5.344

9.  Diaphragmatic Peritoneal Stripping Versus Full-Thickness Resection in CRS/HIPEC: Is There a Difference?

Authors:  Brianne J Sullivan; Eliahu Y Bekhor; Matthew Carpiniello; Natasha L Leigh; Eric R Pletcher; Daniel Solomon; Deepa R Magge; Umut Sarpel; Daniel M Labow; Benjamin J Golas
Journal:  Ann Surg Oncol       Date:  2019-09-09       Impact factor: 5.344

10.  Laparoscopic liver resection with simultaneous diaphragm resection.

Authors:  Airazat M Kazaryan; Davit L Aghayan; Åsmund A Fretland; Vasiliy I Semikov; Alexander M Shulutko; Bjørn Edwin
Journal:  Ann Transl Med       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.